基本信息
浏览量:30
职业迁徙
个人简介
His research interests focus on the cellular and molecular mechanisms of inflammation and autoimmunity in chronic rheumatic conditions particularly rheumatoid arthritis (RA). He was the Chief Investigator of the first 2 stratified, biopsydriven, multicentre, randomised clinical trials in rheumatoid arthritis (RA) which were funded by the NIHR and MRC/VA (R4RA and STRAP). The results of the R4RA trial were published in The Lancet in January 2021. These RCTs are the first worldwide biopsy-driven trials that span the disease course from early to late RA and are synchronised for drug exposure. This programme has led to the definition of specific pathobiological phenotypes linked to clinical and treatment response endotypes, as recently published in Cell Reports (August 2019) for early RA. The ultimate goal of the programme is the delineation of synovial specific signatures able to define a new taxonomy of disease integrating clinical and molecular pathology algorithms to more accurately predict prognosis and treatment response prior to initiation of potentially toxic and expensive therapies, in order to give the right drug to the right patients first time: towards precision medicine.
研究兴趣
论文共 796 篇作者统计合作学者相似作者
按年份排序按引用量排序主题筛选期刊级别筛选合作者筛选合作机构筛选
时间
引用量
主题
期刊级别
合作者
合作机构
Marie-Astrid Boutet,Alessandra Nerviani,Liliane Fossati-Jimack, Rebecca Hands-Greenwood, Manzoor Ahmed,Felice Rivellese,Costantino Pitzalis
OSTEOARTHRITIS AND CARTILAGEno. 2 (2024): 166-176
Alessandra Nerviani,Marie-Astrid Boutet, Giulia Maria Ghirardi,Katriona Goldmann,Elisabetta Sciacca,Felice Rivellese,Elena Pontarini,Edoardo Prediletto, Federico Abatecola,Mattia Caliste,Sara Pagani,Daniele Mauro,
Nature Communicationsno. 1 (2024): 1-16
http://isrctn.com/ (2024)
LANCET RHEUMATOLOGYno. 11 (2023): E648-E659
引用0浏览0引用
0
0
The Lancet. Rheumatologyno. 11 (2023): e648-e659
Bioinformatics advancesno. 1 (2023)
加载更多
作者统计
合作学者
合作机构
D-Core
- 合作者
- 学生
- 导师
数据免责声明
页面数据均来自互联网公开来源、合作出版商和通过AI技术自动分析结果,我们不对页面数据的有效性、准确性、正确性、可靠性、完整性和及时性做出任何承诺和保证。若有疑问,可以通过电子邮件方式联系我们:report@aminer.cn